http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e107a10875195382c1aa8adc27e87b62
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Huntly |
| name | Brian J P Huntly Brian J. P. Huntly |
| given-name | Brian J P Brian J. P. |
| organization-name | Department of Haematology and Wellcome Trust Stem Cell Institute University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom Department of Haematology, Cambridge Institute for Medical Research and Addenbrooke’s Hospital, University of Cambridge, United Kingdom; Wellcome Trust—Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom; Cambridge University Hospitals, Cambridge, United Kingdom Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom; Wellcome Trust–MRC Cambridge Stem Cell Institute; Department of Haematology, University of Cambridge; and Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. From the Department of Hematology and the Applied Medical Statistics Department, University of Cambridge, United Kingdom; Victorian Cancer Cytogenetic Service, St Vincent Hospital, Fitzroy, Australia; the Department of Hematology, City Hospital, Nottingham, United Kingdom; the Department of Hematology, University Hospital, Poitiers, France; and the Department of Hematology, University Hospital, Leipzig, Germany. Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 2XY, United Kingdom Bone Marrow Transplantation/Leukemia, Oregon Health and Science University, Portland, OR. Correspondence: Elisabeth P. Nacheva, University of Cambridge, Department of Haematology, Cambridge Institute of Medical Research, Hills Rd, Cambridge, CB2 2XY, United Kingdom; e-mail: From the Howard Hughes Medical Institute, Harvard Medical School, and Department of Pathology, Brigham and Women's Hospital, Boston, MA; the Department of Pathology, Emory University, Atlanta, GA; and the Department of Chemistry and Biochemistry, University of California–San Diego, La Jolla, CA. From the Division of Hematology and the Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Center for Human Genetics-Flanders Interuniversity Institute of Biotechnology (VIB), University of Leuven, Belgium; and the DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig, Germany. Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom; and; Cambridge University Foundation Hospital Trust, Cambridge, United Kingdom Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom;; Cambridge University Foundation Hospital Trust, Cambridge, United Kingdom; and Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, United Kingdom; Cambridge University Foundation Hospital Trust, Hills Road, Cambridge CB2 2QQ, United Kingdom From the Department of Hematology, University of Cambridge, Cambridge Institute for Medical Research, United Kingdom; and Harvard Institute of Human Genetics, Harvard Institute of Medicine, Boston, MA. |
Incoming Links
Total number of triples: 56.